- Earth Science Tech, via its subsidiaries, centers on developing its role as a global leader in the cannabinoid arena
- The company’s diverse subsidiaries offer a wide selection of cannabinoid products in numerous categories
- Earth Science Tech recently announced a CBD/Propovit throat spray formula developed via its partnership with Bionatus
A biotechnology enterprise, Earth Science Tech, Inc. (OTCQB: ETST) focuses on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals and medical devices. The company does so through its diverse wholly owned subsidiaries, which concentrate on the development of Earth Science Tech’s role as a worldwide leader in the cannabinoid space. Earth Science Tech is headquartered in Doral, Florida.
The company’s subsidiaries include Earth Science Pharmaceutical, Inc.; Cannabis Therapeutics, Inc.; and KannaBidioiD, Inc. Earth Science Tech’s Canadian subsidiary is Canna Inno Laboratories, Inc. Through its subsidiaries, the company’s cannabinoid products are offered in different forms of personal care goods, homeopathies, vitamins, minerals, herbs, botanicals, functional foods and more (http://cnw.fm/M0Enw).
Subsidiary Earth Science Pharmaceutical focuses on becoming a global leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases (STIs). The Cannabis Therapeutics subsidiary is positioning itself to become an international leader in cannabinoid research and development for a wide-ranging line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions.
Earth Science Tech’s KannaBidioiD subsidiary focuses on manufacturing and distributing vapes/e-liquids and gummy edibles in the recreational arena formulated by its innovative Kanna and cannabinoid formula. Moreover, the Canna Inno Laboratories subsidiary gives Earth Science Tech a position in the Province of Québec. Canna Inno provides the company with access to government grants, with the first now receiving approval.
Recently, Earth Science Tech announced that the new genuine CBD/Propovit throat spray formula developed via a strategic partnership with Bionatus is almost market-ready. The company worked together with Bionatus to improve the Propovit throat spray. The outcome of this collaboration is a strawberry-flavored formulation enriched with Earth Science Tech full-spectrum cannabinoids obtained from industrial hemp (http://cnw.fm/8TBer).
The principal active ingredient in Propovit is propolis. This compound comes from the Brazilian green bee. Propolis has substantial strong antioxidants. It also has potent anti-bacterial, anti-viral, anti-fungal and anti-inflammatory properties. This new formulation unites the effect of Propovit and the company’s cannabinoids to help reduce the symptoms of throat infections. Fine drops distribute the hemp oil extensively onto the oromucosal area of the mouth.
In a news release, Dr. Michel Aube, chief executive officer and chief science officer of Earth Science Tech, stated, “We are very excited to see this project in the final stage. We have developed a product that we believe will have properties not found in any other product on the market, and we thank our team and our partner Bionatus for their diligence and innovation on this formulation.”
Earth Science Tech, by way of its subsidiaries, continues to innovate and advance new initiatives in the cannabinoid space. It is working to bring to market pioneering pharmaceutical and medical device offerings. For investors, Earth Science Tech offers the opportunity for growth through its varied portfolio and pipeline as it looks to expand its role as a leader in diverse market sectors.
For more information, visit the company’s website at www.EarthScienceTech.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
CBDWire is at the epicenter of the Cannabis Revolution.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
